在加拿大放射学家学会会议上,一项关于试验性的研究报道称,肿瘤病人用肠溶阿司匹林(ASA)后,改善放疗引起的局部溃疡、腹泻和肠痉挛等并发症。据不列颠哥伦比亚肿瘤控制机构的放射肿瘤学家Charles Ludgate说,8名病人治疗了2—6个月,每天服用ASA 3次,剂量为325mg,症状明显改善,目前将进行一项前瞻性对照试验,评价ASA在降低辐射反应性中的作用。据报道,坚持服用ASA一个月的8名病 At a meeting of the Canadian Society of Radiologists, an experimental study reported that patients with tumors used enteric-coated aspirin (ASA) to improve complications such as local ulcers, diarrhea, and intestinal spasm caused by radiotherapy. According to Charles Ludgate, a radiation oncologist at the Cancer Control Unit of British Columbia, 8 patients were treated for 2 to 6 months and ASA was administered 3 times daily at a dose of 325 mg. Symptoms improved significantly and a prospective controlled trial is currently being conducted. Evaluate the role of ASA in reducing radiation reactivity. According to reports, 8 patients who insisted on taking ASA for one month